Pier Capital’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-7,960
| Closed | -$484K | – | 106 |
|
|
2022
Q2 | $484K | Sell |
7,960
-2,950
| -27% | -$179K | 0.08% | 96 |
|
|
2022
Q1 | $685K | Buy |
10,910
+1,966
| +22% | +$123K | 0.09% | 97 |
|
|
2021
Q4 | $678K | Buy |
8,944
+2,509
| +39% | +$190K | 0.07% | 104 |
|
|
2021
Q3 | $720K | Buy |
6,435
+61
| +1% | +$6.83K | 0.07% | 107 |
|
|
2021
Q2 | $1.03M | Buy |
+6,374
| New | +$1.03M | 0.1% | 97 |
|